Senna Plus (Cardinal Health)
Welcome to the PulseAid listing for the Senna Plus drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | Sennosides and Docusate Sodium |
SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
Senna Plus HUMAN OTC DRUG Details:
Item Description | Senna Plus from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55154-1877_2003456b-3cf7-4c36-9dbf-ebf6d8f21816 |
PRODUCT NDC: | 55154-1877 |
APPLICATION NUMBER: | part334 |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers: